» Articles » PMID: 39444802

Prevalence and Risk Factors of Subjective Cognitive Decline in Older Adults in Baotou, China: a Cross-sectional Study

Overview
Specialty Geriatrics
Date 2024 Oct 24
PMID 39444802
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Subjective cognitive decline (SCD) as a stage between healthy cognition and early neurocognitive disorders, has been proposed to be helpful in the diagnosis of prodromal neurocognitive disorders. To investigate the prevalence of SCD and the related risk factors on the prevalence.

Methods: A cross-sectional study involving 1,120 elderly subjects residing in Baotou, China. From June 2021 to June 2023, the data were gathered by research assistants with training utilizing standardized questionnaires. The following factors were evaluated: subjective cognitive decline, physical and cognitive activity levels, past medical history, demographics, instrumental activities of daily living, and cognitive function. Risk factors of SCD were used chi-square tests and multivariate logistic regression analysis.

Results: The prevalence of SCD was 43.8%. Permanent residence, marital status, BMI, dietary habits, average sleep duration per night, smoking, diabetes, coronary heart disease, and visual impairment were significantly associated with SCD ( < 0 0.05). Multivariable logistic regression analysis showed obesity, vegetarian-based, smoking for a long time, diabetes and coronary heart disease, visual impairment, no spouse, and average sleep duration per night <6 h were independent risk factors for SCD. Based on the gender analysis, the difference in marital status, dietary habits, average sleep duration per night, smoking, drinking, and hypertension was statistically significant ( < 0.001).

Conclusion: The prevalence of subjective cognitive decline was high among elder adults. We discovered significant differences in the prevalence or risk factors for SCD between men and women based on their sex. This study provides a more theoretical basis for the early prevention and screening of cognitive impairment diseases in the elderly population.

References
1.
Palmqvist S, Janelidze S, Quiroz Y, Zetterberg H, Lopera F, Stomrud E . Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020; 324(8):772-781. PMC: 7388060. DOI: 10.1001/jama.2020.12134. View

2.
Amini R, Sahli M, Ganai S . Cigarette smoking and cognitive function among older adults living in the community. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020; 28(4):616-631. DOI: 10.1080/13825585.2020.1806199. View

3.
Palermo S . Covid-19 Pandemic: Maximizing Future Vaccination Treatments Considering Aging and Frailty. Front Med (Lausanne). 2020; 7:558835. PMC: 7530612. DOI: 10.3389/fmed.2020.558835. View

4.
Lin L, Wang S, Xu W, Hu Q, Zhang P, Ke Y . Subjective cognitive decline symptoms and its association with socio-demographic characteristics and common chronic diseases in the southern Chinese older adults. BMC Public Health. 2022; 22(1):127. PMC: 8767737. DOI: 10.1186/s12889-022-12522-4. View

5.
Rabin L, Smart C, Crane P, Amariglio R, Berman L, Boada M . Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J Alzheimers Dis. 2015; 48 Suppl 1:S63-86. PMC: 4617342. DOI: 10.3233/JAD-150154. View